Henrik Andersen: How smart planning helps CGT scale further, faster

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Henrik Andersen, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, to explore how early planning, automation, and economic discipline can help scale the impact of cell therapies. Henrik draws on his experience in both biologics and cell therapy to discuss how platform thinking, target product profiles, and cost-of-goods modelling can be applied earlier in development. Together, they reflect on the pitfalls of rushing to clinic without a viable manufacturing strategy, the shift in investor expectations, and why adapting lessons from biologics could help CGT companies avoid costly detours on the path to commercial success. Connect with Henrik

You can listen to Henrik Andersen: How smart planning helps CGT scale further, faster online on Radio and Podcast. Open the player on this page to stream the available audio.

Henrik Andersen: How smart planning helps CGT scale further, faster is an episode from Ori Spotlight by Ori Biotech.

This episode is 00:54:20 long.

This episode was published on Jul 15, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Ori Spotlight when more episodes are available from the podcast feed.